Cetuximab-induced natural killer cell cytotoxicity in head and neck squamous cell carcinoma cell lines: investigation of the role of cetuximab sensitivity and HPV status
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cetuximab-induced natural killer cell cytotoxicity in head and neck squamous cell carcinoma cell lines: investigation of the role of cetuximab sensitivity and HPV status
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CANCER
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-06-26
DOI
10.1038/s41416-020-0934-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Relationship Between EGFR Expression in Oral Cancer Cell Lines and Cetuximab Antibody-dependent Cell-mediated Cytotoxicity
- (2019) HIROSHI NAKAMURA et al. ANTICANCER RESEARCH
- Heterogeneity of the Head and Neck Squamous Cell Carcinoma Immune Landscape and Its Impact on Immunotherapy
- (2019) Madison Canning et al. Frontiers in Cell and Developmental Biology
- Oncolytic activity of HF10 in head and neck squamous cell carcinomas
- (2019) Shinichi Esaki et al. CANCER GENE THERAPY
- Analyzing expression and phosphorylation of the EGF receptor in HNSCC
- (2019) Malte Kriegs et al. Scientific Reports
- In Vitro Killing of Colorectal Carcinoma Cells by Autologous Activated NK Cells is Boosted by Anti-Epidermal Growth Factor Receptor-induced ADCC Regardless of RAS Mutation Status
- (2018) Ilaria Turin et al. JOURNAL OF IMMUNOTHERAPY
- Simultaneous targeting of EGFR, HER2, and HER4 by afatinib overcomes intrinsic and acquired cetuximab resistance in head and neck squamous cell carcinoma cell lines
- (2018) Ines De Pauw et al. Molecular Oncology
- Different responses of colorectal cancer cells to alternative sequences of cetuximab and oxaliplatin
- (2018) Elli Narvi et al. Scientific Reports
- EGFR Downregulation after Anti-EGFR Therapy Predicts the Antitumor Effect in Colorectal Cancer
- (2017) Yasuyuki Okada et al. MOLECULAR CANCER RESEARCH
- ADCC responses and blocking of EGFR-mediated signaling and cell growth by combining the anti-EGFR antibodies imgatuzumab and cetuximab in NSCLC cells
- (2017) Arjan Kol et al. Oncotarget
- Epidermal Growth Factor Receptor Inhibitors: Coming of Age
- (2017) Amit Mahipal et al. Cancer Control
- The promise of immunotherapy in head and neck squamous cell carcinoma
- (2016) P. Economopoulou et al. ANNALS OF ONCOLOGY
- Cetuximab Resistance in Head and Neck Cancer Is Mediated by EGFR-K 521 Polymorphism
- (2016) Friederike Braig et al. CANCER RESEARCH
- Anti-EGFR Targeted Monoclonal Antibody Isotype Influences Antitumor Cellular Immunity in Head and Neck Cancer Patients
- (2016) S. Trivedi et al. CLINICAL CANCER RESEARCH
- CD56-positive lymphocyte infiltration in relation to human papillomavirus association and prognostic significance in oropharyngeal squamous cell carcinoma
- (2016) Steffen Wagner et al. INTERNATIONAL JOURNAL OF CANCER
- The EGFR-specific antibody cetuximab combined with chemotherapy triggers immunogenic cell death
- (2016) Chiara Pozzi et al. NATURE MEDICINE
- Current relevance of hypoxia in head and neck cancer
- (2016) Marius G. Bredell et al. Oncotarget
- Prognostic and predictive value of EGFR in head and neck squamous cell carcinoma
- (2016) Paolo Bossi et al. Oncotarget
- The relevance of ADCC for EGFR targeting: A review of the literature and a clinically-applicable method of assessment in patients
- (2015) Martino Monteverde et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Unlocking the potential of CD70 as a novel immunotherapeutic target for non-small cell lung cancer
- (2015) Julie Jacobs et al. Oncotarget
- Ex Vivo Antibody-Dependent Cellular Cytotoxicity Inducibility Predicts Efficacy of Cetuximab
- (2015) Rodney J. Taylor et al. Cancer Immunology Research
- EGFR Modulates DNA Synthesis and Repair through Tyr Phosphorylation of Histone H4
- (2014) Ruey-Hwang Chou et al. DEVELOPMENTAL CELL
- Randomized Phase III Trial of Concurrent Accelerated Radiation Plus Cisplatin With or Without Cetuximab for Stage III to IV Head and Neck Carcinoma: RTOG 0522
- (2014) K. Kian Ang et al. JOURNAL OF CLINICAL ONCOLOGY
- The immune response in HPV+oropharyngeal cancer
- (2014) Emma V King et al. OncoImmunology
- A Phase III open-label, randomized, multicenter study of imprime pgg in combination with cetuximab in patients with kras wild type metastatic colorectal cancer
- (2014) Jeffrey A Meyerhardt et al. Journal for ImmunoTherapy of Cancer
- Hypoxia downregulates the expression of activating receptors involved in NK-cell-mediated target cell killing without affecting ADCC
- (2013) Mirna Balsamo et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Anti-Epidermal Growth Factor Receptor Therapy in Head and Neck Squamous Cell Carcinoma: Focus on Potential Molecular Mechanisms of Drug Resistance
- (2013) C. Boeckx et al. ONCOLOGIST
- Hypoxia Induced Impairment of NK Cell Cytotoxicity against Multiple Myeloma Can Be Overcome by IL-2 Activation of the NK Cells
- (2013) Subhashis Sarkar et al. PLoS One
- The Intriguing Interplay Between Therapies Targeting the Epidermal Growth Factor Receptor, the Hypoxic Microenvironment and Hypoxia-inducible Factors
- (2012) An Wouters et al. CURRENT PHARMACEUTICAL DESIGN
- Predictive value of epidermal growth factor receptor expression for first-line chemotherapy plus cetuximab in patients with head and neck and colorectal cancer: Analysis of data from the EXTREME and CRYSTAL studies
- (2012) Lisa Licitra et al. EUROPEAN JOURNAL OF CANCER
- Comparative Analysis of Dynamic Cell Viability, Migration and Invasion Assessments by Novel Real-Time Technology and Classic Endpoint Assays
- (2012) Ridha Limame et al. PLoS One
- Lack of Correlation between Epidermal Growth Factor Receptor Status and Response to Panitumumab Monotherapy in Metastatic Colorectal Cancer
- (2010) J. R. Hecht et al. CLINICAL CANCER RESEARCH
- Chemoradiation interactions under reduced oxygen conditions: Cellular characteristics of an in vitro model
- (2009) An Wouters et al. CANCER LETTERS
- Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer
- (2008) Jan B. Vermorken et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More